BrightHeart

French tech company | Builders Republic

About

FDA-cleared AI software for prenatal ultrasound that helps sonographers and OB/GYNs screen the fetal heart for congenital defects — automatically analyzing standard cardiac views to flag structural abnormalities, developed within Sofinnova's MD Start medtech studio.

Key facts

Status
Active
Sectors
Healthcare & Life Sciences
Latest stage
Series A
Founded
2022
City
PARIS
Region
IDF
Tracked rounds
2
Amount raised
13 M€ raised since 2020

Funding rounds

  • Series A — 2026
  • Seed — 2023

Investors